AOD-9604: What It Is and How It's Used in the Philippines

Quick read: AOD-9604 is a modified fragment of growth hormone (amino acids 176-191) that promotes fat oxidation without elevating IGF-1. Dosed at 300-500mcg sub-q daily fasted, it's used for fat loss without GH side effects. In PH, it's an alternative for users wanting fat loss without GLP-1 appetite suppression, though data is mixed on effectiveness.

What it is

AOD-9604 (Advanced Obesity Drug) is a synthetic peptide derived from the C-terminal fragment of human growth hormone. It mimics GH's lipolytic (fat-burning) effects without affecting blood sugar or IGF-1.

The mechanism: AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage), particularly in adipose tissue. Unlike full-length GH, it doesnt bind to GH receptors, so it doesnt elevate IGF-1.

Research is limited. Early studies showed promise for fat loss, but a large Phase 2b/3 trial failed to meet endpoints, leading to abandonment by the original developer. Community use persists based on anecdotal reports.

In the PH peptide community, AOD-9604 is used by people who want fat loss support without GLP-1 appetite suppression or GH side effects (water retention, joint pain).

What it's used for

Primary use: Fat loss without IGF-1 elevation. Users run AOD-9604 during caloric deficits to support fat oxidation.

Secondary use: Alternative to GLP-1 agonists. For users who cant tolerate GLP-1 appetite suppression but want metabolic support.

Realistic expectations: Results are mixed. Some users report modest fat loss (1-2kg over 8 weeks). Others see no benefit. Data is inconclusive.

Typical protocols

Fat loss protocol:

• Dose: 300-500mcg sub-q daily
• Timing: Morning, fasted (before cardio or breakfast)
• Duration: 8-12 weeks

Pin location: Subcutaneous, abdomen.

What users typically report

Week 1-4: Minimal noticeable effects. Some users report feeling slightly warmer (increased thermogenesis).

Week 5-8: Modest fat loss reported by some users. Others see no change.

Variance: Response is highly individual. Effectiveness is debated in the community.

Common side effects

Side effects are minimal.

Injection site irritation (5%): Mild redness or swelling.

Mild fatigue (rare, <5%): Occasionally reported.

Serious side effects are not documented.

Side effect management

Injection site irritation: Rotate sites.

Fatigue: Ensure adequate calorie intake (AOD-9604 doesnt suppress appetite, so undereating is less common).

Who this compound is for

AOD-9604 is for users seeking fat loss support without GLP-1 appetite suppression or GH side effects. Popular among PH users who want metabolic support during cuts.

Who this compound is NOT for

Pregnancy/breastfeeding: No safety data.

People expecting dramatic fat loss: AOD-9604 data is mixed. Results are modest at best.

PH-specific considerations

Alternative for users wanting fat loss without GLP-1 sides: Some PH users cant tolerate retatrutide or semaglutide appetite suppression. AOD-9604 is an alternative, though effectiveness is unclear.

Data is mixed: Community opinions on AOD-9604 are split. Some swear by it, others see no benefit.

Common stacks

AOD-9604 + Tesamorelin: For dual-mechanism fat loss (AOD for lipolysis, Tesamorelin for visceral fat via GH).

AOD-9604 + MOTS-c: For metabolic support during cuts.

Things to watch

AOD-9604 doesnt require bloodwork.

Subjective metrics:

• Body weight (weekly)
• Waist circumference
• Body composition (DEXA or mirror check)

Coming off / cycling

Stop cold after 8-12 weeks. No rebound effect.

Related compounds

• Tesamorelin — GH analog for visceral fat
• MOTS-c — Metabolic support
• CJC + Ipamorelin — GH stack for fat loss and muscle retention

Sources

• Heffernan 2001 — AOD-9604 fat loss mechanisms
• Ng 2000 — GH fragment lipolytic effects

Last updated: 2026-05-20. This page is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.